<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - European Union Drugs Agency (short presentation) - Monday, 12 June 2023</title><meta name="title" content="Verbatim report of proceedings - European Union Drugs Agency (short presentation) - Monday, 12 June 2023" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2023 - Source: European Parliament" /><meta name="available" content="12-06-2023" /><meta name="sipade-leg" content="9" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - European Union Drugs Agency (short presentation) - Monday, 12 June 2023" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-9-2023-06-12-ITM-019_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_FR.html">fr - français</a></li>
            <li><a title="ga - Gaeilge" class="ga on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_GA.html">ga - Gaeilge</a></li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-9-2023-06-12-ITM-019_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2023-06-12-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2023-06-12-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2023-06-12-ITM-018_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2023-06-12-ITM-018_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-9-2023-06-12-ITM-020_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-9-2023-06-12-ITM-020_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2023-06-12_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2023-06-12_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table>
                <table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td align="left"><span class="contents">Procedure : </span><a class="ring_ref_link" href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2022/0009(COD)">2022/0009(COD)</a></td><td align="right"><table align="right" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><img src="/doceo/data/img/ring_tabs_left_doc_unselected.gif" height="19" width="4" alt="" /></td><td class="Tabs_doc_unselected"><img src="/doceo/data/img/ring_navi.gif" width="17" height="14" alt="" />Document stages in plenary</td><td valign="middle"><img src="/doceo/data/img/ring_tabs_right_doc_unselected.gif" height="19" width="4" alt="" /></td></tr></tbody></table></td></tr></tbody></table><table class="doc_box_header" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="ring_multiple_bg" valign="top" colspan="7">Document selected :
            <span class="ring_ref_selected_header">A9-0289/2022</span></td></tr><tr><td width="25%" valign="top" class="ring_step_bg1" nowrap="nowrap"><p class="ring_step_title">Texts tabled :</p>
                        <a href="/doceo/document/A-9-2022-0289_EN.html" class="ring_ref_link">A9-0289/2022</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg1.gif)"><img src="/doceo/data/img/ring_flech1.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg2" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Debates :</p>
                        <a href="/doceo/document/PV-9-2023-06-12-ITM-019_EN.html" class="ring_ref_link">PV 12/06/2023 - 19</a><br />
                        <a class="ring_ref_selected">CRE 12/06/2023 - 19</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg2.gif)"><img src="/doceo/data/img/ring_flech2.gif" width="13" height="22" border="0" alt="" /></td><td class="ring_step_bg3" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Votes :</p>
                        <a href="/doceo/document/PV-9-2023-06-13-ITM-006-07_EN.html" class="ring_ref_link">PV 13/06/2023 - 6.7</a><br />
                        <a href="/doceo/document/CRE-9-2023-06-13-ITM-019-03_EN.html" class="ring_ref_link">Explanations of votes</a><br />
                    </td><td width="19" style="background-image:url(/doceo/data/img/ring_bg3.gif)"><img src="/doceo/data/img/ring_flech3.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg4" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Texts adopted :</p>
                        <a href="/doceo/document/TA-9-2023-0226_EN.html" class="ring_ref_link">P9_TA(2023)0226</a><br />
                    </td></tr></tbody></table><br />
            <table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)">
<table border="0" cellspacing="0" cellpadding="0"><tr>
<td><a href="/doceo/document/CRE-9-2023-06-12-ITM-019_EN.xml"><img src="/doceo/data/img/formats/icn_xml.gif" border="0" align="bottom" alt="XML" title="XML" /></a><span class="doc_size"> 18k</span></td></tr>
</table></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Monday, 12 June 2023 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 19. European Union Drugs Agency (short presentation)</td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table cellSpacing="0" cellPadding="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:39:49&amp;playerEndTime=20230612-20:51:35" target="_blank"><img width="29" height="20" src="/doceo/data/img/vod_all_speakers_left.gif" border="0" /></a></td><td class="switch_button_pv_cre"><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:39:49&amp;playerEndTime=20230612-20:51:35" target="_blank">Video of the speeches</a></td><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:39:49&amp;playerEndTime=20230612-20:51:35" target="_blank"><img width="5" height="20" src="/doceo/data/img/switch_pv_cre_right.gif" border="0" /></a></td></tr></table></td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table align="right" cellpadding="0" cellspacing="0"><tr><td><a href="/doceo/document/PV-9-2023-06-12-ITM-019_EN.html" title="Minutes"><img src="/doceo/data/img/switch_pv_cre_left.gif" width="22" height="20" border="0" alt="" /></a></td><td class="switch_button_pv_cre"><a href="/doceo/document/PV-9-2023-06-12-ITM-019_EN.html" title="Minutes">PV</a></td><td><a href="/doceo/document/PV-9-2023-06-12-ITM-019_EN.html" title="Minutes"><img src="/doceo/data/img/switch_pv_cre_right.gif" width="5" height="20" border="0" alt="" /></a></td></tr></table></td></tr></table>
<a name="1-174-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96998.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:39:49&amp;playerEndTime=20230612-20:40:05" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Die Präsidentin. – </span></span>  Als nächster Punkt der Tagesordnung folgt die kurze Darstellung des Berichts von Isabel Santos über den Vorschlag für eine Verordnung des Europäischen Parlaments und des Rates über die Drogenagentur der Europäischen Union (<a href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2022/0009(COD)">2022/0009(COD)</a>) (<a href="/doceo/document/A-9-2022-0289_EN.html">A9-0289/2022</a>).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-175-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197650.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:40:05&amp;playerEndTime=20230612-20:44:15" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Isabel Santos, </span></span>  <span class="italic">relatora</span><span class="bold">.</span> – Senhora Presidente, Cara Comissária, Caras e Caros colegas, passados 30 anos sobre a criação do Observatório Europeu da Droga e da Toxicodependência e 28 anos sobre a sua entrada em funcionamento, aqui estamos a assinalar um percurso de reconhecido sucesso e a dar um último passo rumo à instituição da Agência da União Europeia sobre Drogas. Um passo à altura dos desafios que nos são colocados por dinâmicas de mercado e de consumo cada vez mais complexas, que nos exigem uma nova capacidade de intervenção e de desenho das políticas.</p>
<p class="contents">Mas permitam que, antes de mais, sublinhe – porque é justo que o faça – a atitude cooperante e construtiva dos relatores-sombra, bem como o esforço de convergência feito pelas três instituições – Parlamento, Comissão e Conselho – que nos permitiu chegar a este acordo provisório, definidor do mandato da nova Agência da União Europeia sobre Drogas. Um mandato reforçado, centrado numa abordagem integrada e multidisciplinar deste fenómeno, do ponto de vista da complexidade das dinâmicas dos mercados e dos consumos, da saúde, do tratamento, da reinserção social e da segurança.</p>
<p class="contents">Num momento em que o aumento das drogas disponíveis, a variedade crescente de meios de circulação e comercialização e a alteração, até, das geografias de produção nos colocam diante da exigência de respostas mais eficazes e de competências reforçadas na antecipação de cenários, cá estamos a instituir uma nova Agência onde as questões relacionadas com a saúde, a prevenção, o tratamento e a reinserção social caminham lado a lado, como foi exigência do Parlamento Europeu.</p>
<p class="contents">Uma Agência, sublinhe-se, dotada de uma reforçada capacidade de envolvimento da sociedade civil, o que constitui uma inequívoca mais-valia no cumprimento da sua missão. A nova Agência contará com um orçamento mais robusto como há muito se mostrava necessário, uma maior dotação de recursos humanos, mais autonomia e capacidade de ação.</p>
<p class="contents">O reforço da rede de pontos focais permitirá uma mais ampla recolha e análise de dados, produção de informação, bem como de deteção de novas dinâmicas de mercado e de consumo, além da emissão de alertas rápidos. Avançamos, assim, de forma decidida, no aprofundamento de uma abordagem pragmática, equilibrada e cientificamente fundada, que sedimentámos ao longo de 28 anos.</p>
<p class="contents">O Observatório foi um instrumento essencial para a construção de respostas integradas e sustentadas ao nível da União e dos Estados-Membros, como bem atesta a sua reputação dentro e fora da União Europeia. E a Agência continuará a sê-lo de um modo reforçado, sendo agora criadas condições para uma maior cooperação internacional, com a qual todos temos muito a ganhar.</p>
<p class="contents">Estou convicta de que a Agência, aumentando a capacidade de colocar informação baseada em evidências científicas ao dispor das instituições europeias e dos Estados—Membros, contribuirá para um progresso significativo das políticas públicas, dotando-as de maior eficácia e eficiência na resposta às necessidades presentes e futuras.</p>
<p class="contents">O momento de aprovação deste acordo provisional é, sem dúvida, de enorme satisfação, no entanto, o nosso trabalho não acaba aqui. Uma agência preparada para o futuro e que cumpra integralmente o mandato que agora lhe outorgamos exigirá a implementação efetiva do seu regulamento. Uma missão que nos caberá a todos, tanto no escrutínio da Agência aqui no Parlamento, como através dos representantes por nós designados no seu Conselho de Administração. Vamos a isto!</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-176-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:44:14&amp;playerEndTime=20230612-20:44:37" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="italic">Spontane Wortmeldungen</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-177-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124704.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:44:29&amp;playerEndTime=20230612-20:45:49" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Stanislav Polčák (PPE).</span></span>   – Madam President, the issue of drug abuse represents one of the most pressing challenges faced by our society. It is absolutely essential that we focus on international cooperation, increasing the protection of young and vulnerable individuals and drug prevention efforts. Only through collective efforts can we discover more effective ways to limit the drug supply. Drugs know no borders and their impacts affect people worldwide. I consider it is crucial that we have to collaborate at the international level. Only through this approach we can share information, proven methods and innovation in the fight against drugs. Youth and people living in social disadvantaged conditions are most vulnerable to the dangers associated with drugs. Therefore, we should emphasise the provision of information, education and support to these drugs. The most effective approach to addressing this issue is prevention, which should be based on scientific knowledge and proven methods. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-178-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197838.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:45:52&amp;playerEndTime=20230612-20:47:02" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Juozas Olekas (S&amp;D).</span></span>   – Gerbiama Pirmininke. Pirmiausia aš noriu padėkoti savo kolegei Izabelai Santos už tokį puikų siūlymą ir pranešimą. Iš tikrųjų, narkotikų banga yra gal net baisesnė negu mūsų neseniai pergyventas kovidas, ypatingai, kad narkotikai skverbiasi į jauno mūsų europiečio pasaulį, mokyklas ir kitur. Todėl, iš tikrųjų, pasiūlymas, kad būtų tokia agentūra ir būtų surenkama visa informacija, duomenys ir mes galėtume Europoje turėti bendrą politiką. Aš manau, kad tai yra labai vertinga. Kaip gydytojas galiu pasakyti, kad šiuo atveju man profilaktikos, užkardymas labiausiai pasiteisintų, nes kitos priemonės – jau gydymas, vėliau – reabilitacija, žymiai brangiau kainuoja ir ne tokį pasiekia rezultatą. Todėl bendras europinis požiūris, kuris leistų mums pasidalinti ta informacija, kas yra geriausia pasiekta pasaulyje ir siūloma mokslo, tikrai padėtų prisidėti prie pažangos ir jaunų europiečių išsaugojimo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-179-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197817.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:47:09&amp;playerEndTime=20230612-20:48:15" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mick Wallace (The Left).</span></span>   – Madam President, the amendments are much stronger than the Commission’s proposals for a wider mandate on creating an EU drugs agency by extending the powers of the European Monitoring Centre for Drugs and Drug Addiction. The 2022 European Drug Report highlights alarming trends in illicit drug use, which demands the need for better harm-reduction mechanisms. The development of this would be a step towards providing an evidence-based approach centred on human rights in the area of drug policy, which sadly we don’t have, especially in terms of coordinating with national authorities to collect data, establishing a network of toxicology laboratories and promoting best practice in the area of prevention, risk and harm reduction, treatment, care and rehabilitation.</p>
<p class="contents">The question is, will there be an adequate budget with the new broadened mandate in the capacity for analysis, monitoring, developing awareness campaigns, and will there be proper resources to be able to complete this ambitious proposal?</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-180-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:48:14&amp;playerEndTime=20230612-20:48:25" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="italic">(Ende der spontanen Wormeldungen)</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-181-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:48:24&amp;playerEndTime=20230612-20:51:19" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Margrethe Vestager,</span></span>   <span class="italic">Executive Vice-President of the Commission</span><span class="bold">.</span> – Honourable Members, the drug situation within the European Union and at the global level is serious and worrying. </p>
<p class="contents">The threats posed by organised criminal groups trafficking in drugs is increasing in all EU countries. According to the serious and organised crime threat assessment prepared by Europol, 40 % of criminal networks engage in drugs trafficking. The increased criminal activities of organised groups have led to a wave also of extreme violence. Criminal groups threaten democratic values by using corruption to undermine our institutions and, of course, also the rule of law. </p>
<p class="contents">The production and trafficking of illegal drugs is also a threat, obviously, to the health of EU citizens. We see an unprecedented increase in the availability in illicit drugs, while those are often more affordable and have a high potency and purity. This means that more people may have access to drugs and that those drugs may be at greater risk, and those who use those drugs may be at greater risk of adverse health outcomes, including poisoning and death. </p>
<p class="contents">We have a good basis for action in the EU drugs strategy 2021–2025 and the EU strategy to tackle organised crime, also 2021–2025. And the Commission considers that the European Union’s drugs agency needs additional competences, tools and resources to better address the health and security dimension of the drugs phenomenon. </p>
<p class="contents">And we want the agency’s work to be forward looking, as also mentioned by several today. The Commission’s proposal sought to expand the agency’s mandate to cover product supplies, as well as poly drug use and to better equip it to forecast and analyse how these is increasing. All the changes to the agency’s mandate are important and necessary in order to ensure that it can play a greater role at the EU and, of course, internationally. </p>
<p class="contents">The Commission thanks, wholeheartedly, the rapporteur, Ms Santos, and the shadow rapporteurs for an excellent cooperation and a great work on this important file. </p>
<p class="contents">Our aim is to ensure a quick and full application of the new mandates by mid-24. For that, the Commission, of course, encourages Parliament to adopt the new mandate for the agency on Thursday. Thank you very much and thank you for the cooperation. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-182-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96998.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20230612-20:51:18&amp;playerEndTime=20230612-20:51:35" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Die Präsidentin. – </span></span>  Damit ist dieser Tagesordnungspunkt geschlossen.</p>
<p class="contents">Die Abstimmung findet am Dienstag, 13. Juni 2023, statt.</p>
<p class="contents"><span class="bold"><span class="italic">Schriftliche Erklärungen (Artikel 171)</span></span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="1-182-5000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124861.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Caterina Chinnici (PPE), </span></span>  <span class="italic">per iscritto</span><span class="bold">.</span> – Le droghe e le tossicodipendenze causano enormi danni alla salute delle persone, principalmente ai giovani, e alla società nel suo insieme. Il traffico di stupefacenti rappresenta, inoltre, una delle principali fonti di reddito della criminalità organizzata. </p>
<p class="contents">L'Unione europea deve necessariamente dotarsi di strumenti più incisivi per combattere tale flagello, così da affrontare con più efficacia tale sfida a livello UE. Bene quindi l'accordo raggiunto a seguito dei negoziati interistituzionali che trasformerà l'attuale Osservatorio europeo delle droghe e delle tossicodipendenze di Lisbona in un'agenzia a pieno titolo. </p>
<p class="contents">La raccolta e l'analisi dei dati continuerà ad essere il compito principale dell'Agenzia europea per la droga, che tuttavia, in base al nuovo regolamento, sarà in grado di rispondere più efficacemente alle gravi sfide per la salute e la sicurezza poste dal consumo di droghe.</p>
<p class="contents">Avrà, infatti, un ruolo rafforzato nel settore della cooperazione internazionale, in modo da interagire pienamente con i Paesi terzi; potrà approfondire le dinamiche del mercato della droga per meglio comprenderne l'impatto sulla salute pubblica, come il crescente consumo di poli-sostanze (sostanze lecite e droghe), purtroppo, sempre più comune fra i giovani, e lavorare per ridurre la disponibilità di droga nell'UE al fine, si spera, di frenarne la domanda.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td>Last updated: 22 August 2023</td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
